• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bayer AG

Bayer AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Bayer AG Fourth-Quarter Net Profit Falls 26%

    Bayer AG Fourth-Quarter Net Profit Falls 26%

  2. Resistant Hypertension - Pipeline Review, H2 2016 - Key Players are Bayer AG , Novartis AG, Sarfez Pharmaceuticals , PhaseBio Pharmaceuticals & Zumbro Discovery - Research and Markets

    Resistant Hypertension - Pipeline Review, H2 2016 - Key Players are Bayer AG , Novartis AG, Sarfez Pharmaceuticals , PhaseBio Pharmaceuticals & Zumbro Discovery - Research and Markets

  3. Upbeat Bayer Posts Lower Profit With Monsanto in its Sights--Update

    Upbeat Bayer Posts Lower Profit With Monsanto in its Sights--Update

  4. North America Contrast Media Injectors Market Outlook to 2022: Key Players Covered include Bayer HealthCare AG, Guerbet SA, Bracco Imaging S.p.A - Research and Markets

    North America Contrast Media Injectors Market Outlook to 2022: Key Players Covered include Bayer HealthCare AG, Guerbet SA, Bracco Imaging S.p.A - Research and Markets

  5. UPDATE: European stocks flatten at the close as euro pulls back

    UPDATE: European stocks flatten at the close as euro pulls back

  6. European stocks at yearly highs as euro pulls back, German sentiment rises

    European stocks at yearly highs as euro pulls back, German sentiment rises

  7. EUROPE MARKETS: European Stocks At Yearly Highs As Euro Pulls Back, German Sentiment Rises

    EUROPE MARKETS: European Stocks At Yearly Highs As Euro Pulls Back, German Sentiment Rises

  8. UPDATE: European stocks at yearly highs as euro pulls back, German sentiment rises

    UPDATE: European stocks at yearly highs as euro pulls back, German sentiment rises

  9. EUROPE MARKETS: European Stocks At Yearly Highs As Euro Pulls Back, German Sentiment Rises

    EUROPE MARKETS: European Stocks At Yearly Highs As Euro Pulls Back, German Sentiment Rises

  10. Women's Health Medical Devices Pipeline Assessment 2016 - Research and Markets

    Women's Health Medical Devices Pipeline Assessment 2016 - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.